Answers are grounded in this paper and cite their sources.
Both the 80-mg dose and the 100-mg dose of resmetirom were superior to placebo with respect to NASH resolution and improvement in liver fibrosis by at least one stage. (Funded by Madrigal Pharmaceuticals; MAESTRO-NASH ClinicalTrials.gov number, NCT03900429.).
No takes yet. Share an insight, caveat, or question.
Harrison et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: